<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1989-07-01" modified="2020-10-07" version="235">
<accession>P11274</accession>
<accession>P78501</accession>
<accession>Q12842</accession>
<accession>Q4LE80</accession>
<accession>Q6NZI3</accession>
<name>BCR_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="38">Breakpoint cluster region protein</fullName>
<ecNumber evidence="21">2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Renal carcinoma antigen NY-REN-26</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="40">BCR</name>
<name type="synonym">BCR1</name>
<name type="synonym">D22S11</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1988" name="Oncogene" volume="2" first="113" last="117">
<title>bcr genes and transcripts.</title>
<authorList>
<person name="Lifshitz B."/>
<person name="Fainstein E."/>
<person name="Marcelle C."/>
<person name="Shtivelman E."/>
<person name="Amson R."/>
<person name="Gale R.P."/>
<person name="Canaani E."/>
</authorList>
<dbReference type="PubMed" id="3285291"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>VARIANT SER-796</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="Genomics" volume="27" first="67" last="82">
<title>Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation.</title>
<authorList>
<person name="Chissoe S.L."/>
<person name="Bodenteich A."/>
<person name="Wang Y.-F."/>
<person name="Wang Y.-P."/>
<person name="Burian D."/>
<person name="Clifton S.W."/>
<person name="Crabtree J."/>
<person name="Freeman A."/>
<person name="Iyer K."/>
<person name="Jian L."/>
<person name="Ma Y."/>
<person name="McLaury H.-J."/>
<person name="Pan H.-Q."/>
<person name="Sarhan O.H."/>
<person name="Toth S."/>
<person name="Wang Z."/>
<person name="Zhang G."/>
<person name="Heisterkamp N."/>
<person name="Groffen J."/>
<person name="Roe B.A."/>
</authorList>
<dbReference type="PubMed" id="7665185"/>
<dbReference type="DOI" id="10.1006/geno.1995.1008"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>CHROMOSOMAL TRANSLOCATION</scope>
</reference>
<reference key="3">
<citation type="submission" date="2005-03" db="EMBL/GenBank/DDBJ databases">
<title>Preparation of a set of expression-ready clones of mammalian long cDNAs encoding large proteins by the ORF trap cloning method.</title>
<authorList>
<person name="Nakajima D."/>
<person name="Saito K."/>
<person name="Yamakawa H."/>
<person name="Kikuno R.F."/>
<person name="Nakayama M."/>
<person name="Ohara R."/>
<person name="Okazaki N."/>
<person name="Koga H."/>
<person name="Nagase T."/>
<person name="Ohara O."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT SER-796</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1987" name="EMBO J." volume="6" first="115" last="119">
<title>cDNA sequence for human bcr, the gene that translocates to the abl oncogene in chronic myeloid leukaemia.</title>
<authorList>
<person name="Hariharan I.K."/>
<person name="Adams J.M."/>
</authorList>
<dbReference type="PubMed" id="3107980"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1987.tb04727.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-872</scope>
<scope>CHROMOSOMAL TRANSLOCATION</scope>
<scope>INVOLVEMENT IN CML</scope>
<scope>VARIANT SER-796</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1986" name="Proc. Natl. Acad. Sci. U.S.A." volume="83" first="9768" last="9772">
<title>Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome.</title>
<authorList>
<person name="Mes-Masson A.-M."/>
<person name="McLaughlin J."/>
<person name="Daley G.Q."/>
<person name="Paskind M."/>
<person name="Witte O.N."/>
</authorList>
<dbReference type="PubMed" id="3540951"/>
<dbReference type="DOI" id="10.1073/pnas.83.24.9768"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-693</scope>
<scope>INVOLVEMENT IN CML</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1987" name="Proc. Natl. Acad. Sci. U.S.A." volume="84" first="2507" last="2507">
<authorList>
<person name="Mes-Masson A.M."/>
<person name="McLaughlin J."/>
<person name="Daley G.Q."/>
<person name="Paskind M."/>
<person name="Witte O.N."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:3540951</scope>
<scope>SEQUENCE REVISION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1985" name="Nature" volume="315" first="758" last="761">
<title>Structural organization of the bcr gene and its role in the Ph' translocation.</title>
<authorList>
<person name="Heisterkamp N."/>
<person name="Stam K."/>
<person name="Groffen J."/>
<person name="de Klein A."/>
<person name="Grosveld G."/>
</authorList>
<dbReference type="PubMed" id="2989703"/>
<dbReference type="DOI" id="10.1038/315758a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 683-1271 (ISOFORM 1)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1990" name="Nucleic Acids Res." volume="18" first="7119" last="7125">
<title>Unique organization of the human BCR gene promoter.</title>
<authorList>
<person name="Zhu Q.S."/>
<person name="Heisterkamp N."/>
<person name="Groffen J."/>
</authorList>
<dbReference type="PubMed" id="2263470"/>
<dbReference type="DOI" id="10.1093/nar/18.23.7119"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-46 AND 275-426</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1987" name="Nature" volume="330" first="386" last="388">
<title>A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia.</title>
<authorList>
<person name="Fainstein E."/>
<person name="Marcelle C."/>
<person name="Rosner A."/>
<person name="Canaani E."/>
<person name="Gale R.P."/>
<person name="Dreazen O."/>
<person name="Smith S.D."/>
<person name="Croce C.M."/>
</authorList>
<dbReference type="PubMed" id="2825022"/>
<dbReference type="DOI" id="10.1038/330386a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 56-426</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1989" name="Oncogene" volume="4" first="93" last="98">
<title>Alternative 5' end of the bcr-abl transcript in chronic myelogenous leukemia.</title>
<authorList>
<person name="Romero P."/>
<person name="Beran M."/>
<person name="Shtalrid M."/>
<person name="Andersson B."/>
<person name="Talpaz M."/>
<person name="Blick M."/>
</authorList>
<dbReference type="PubMed" id="2915904"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 362-438</scope>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1990" name="Blood" volume="75" first="1146" last="1153">
<title>Chronic myeloid leukemia may be associated with several bcr-abl transcripts including the acute lymphoid leukemia-type 7 kb transcript.</title>
<authorList>
<person name="Selleri L."/>
<person name="von Lindern M."/>
<person name="Hermans A."/>
<person name="Meijer D."/>
<person name="Torelli G."/>
<person name="Grosveld G."/>
</authorList>
<dbReference type="PubMed" id="2407300"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 670-842</scope>
<scope>INVOLVEMENT IN CML</scope>
<scope>VARIANT SER-796</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1991" name="Mol. Cell. Biol." volume="11" first="1854" last="1860">
<title>Characterization of the BCR promoter in Philadelphia chromosome-positive and -negative cell lines.</title>
<authorList>
<person name="Shah N.P."/>
<person name="Witte O.N."/>
<person name="Denny C.T."/>
</authorList>
<dbReference type="PubMed" id="1900918"/>
<dbReference type="DOI" id="10.1128/mcb.11.4.1854"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-4</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1991" name="Nature" volume="351" first="400" last="402">
<title>Bcr encodes a GTPase-activating protein for p21rac.</title>
<authorList>
<person name="Diekmann D."/>
<person name="Brill S."/>
<person name="Garrett M.D."/>
<person name="Totty N."/>
<person name="Hsuan J."/>
<person name="Monfries C."/>
<person name="Hall C."/>
<person name="Lim L."/>
<person name="Hall A."/>
</authorList>
<dbReference type="PubMed" id="1903516"/>
<dbReference type="DOI" id="10.1038/351400a0"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1991" name="Cell" volume="66" first="161" last="171">
<title>BCR sequences essential for transformation by the BCR-ABL oncogene bind to the ABL SH2 regulatory domain in a non-phosphotyrosine-dependent manner.</title>
<authorList>
<person name="Pendergast A.M."/>
<person name="Muller A.J."/>
<person name="Havlik M.H."/>
<person name="Maru Y."/>
<person name="Witte O.N."/>
</authorList>
<dbReference type="PubMed" id="1712671"/>
<dbReference type="DOI" id="10.1016/0092-8674(91)90148-r"/>
</citation>
<scope>INTERACTION WITH ABL1 SH2-DOMAIN</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1991" name="Cell" volume="67" first="459" last="468">
<title>The BCR gene encodes a novel serine/threonine kinase activity within a single exon.</title>
<authorList>
<person name="Maru Y."/>
<person name="Witte O.N."/>
</authorList>
<dbReference type="PubMed" id="1657398"/>
<dbReference type="DOI" id="10.1016/0092-8674(91)90521-y"/>
</citation>
<scope>FUNCTION AS PROTEIN KINASE</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1995" name="Proc. Natl. Acad. Sci. U.S.A." volume="92" first="10282" last="10286">
<title>Abr and Bcr are multifunctional regulators of the Rho GTP-binding protein family.</title>
<authorList>
<person name="Chuang T.H."/>
<person name="Xu X."/>
<person name="Kaartinen V."/>
<person name="Heisterkamp N."/>
<person name="Groffen J."/>
<person name="Bokoch G.M."/>
</authorList>
<dbReference type="PubMed" id="7479768"/>
<dbReference type="DOI" id="10.1073/pnas.92.22.10282"/>
</citation>
<scope>FUNCTION</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="33260" last="33270">
<title>The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr.</title>
<authorList>
<person name="Warmuth M."/>
<person name="Bergmann M."/>
<person name="Priess A."/>
<person name="Hauslmann K."/>
<person name="Emmerich B."/>
<person name="Hallek M."/>
</authorList>
<dbReference type="PubMed" id="9407116"/>
<dbReference type="DOI" id="10.1074/jbc.272.52.33260"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-177 BY HCK</scope>
<scope>MUTAGENESIS OF TYR-177</scope>
<scope>INTERACTION WITH HCK AND GRB2</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1999" name="Int. J. Cancer" volume="83" first="456" last="464">
<title>Antigens recognized by autologous antibody in patients with renal-cell carcinoma.</title>
<authorList>
<person name="Scanlan M.J."/>
<person name="Gordan J.D."/>
<person name="Williamson B."/>
<person name="Stockert E."/>
<person name="Bander N.H."/>
<person name="Jongeneel C.V."/>
<person name="Gure A.O."/>
<person name="Jaeger D."/>
<person name="Jaeger E."/>
<person name="Knuth A."/>
<person name="Chen Y.-T."/>
<person name="Old L.J."/>
</authorList>
<dbReference type="PubMed" id="10508479"/>
<dbReference type="DOI" id="10.1002/(sici)1097-0215(19991112)83:4&lt;456::aid-ijc4&gt;3.0.co;2-5"/>
</citation>
<scope>IDENTIFICATION AS A RENAL CANCER ANTIGEN</scope>
<source>
<tissue>Renal cell carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2004" name="Anal. Chem." volume="76" first="2763" last="2772">
<title>Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.</title>
<authorList>
<person name="Brill L.M."/>
<person name="Salomon A.R."/>
<person name="Ficarro S.B."/>
<person name="Mukherji M."/>
<person name="Stettler-Gill M."/>
<person name="Peters E.C."/>
</authorList>
<dbReference type="PubMed" id="15144186"/>
<dbReference type="DOI" id="10.1021/ac035352d"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1264</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2004" name="Exp. Cell Res." volume="299" first="188" last="198">
<title>The c-Fes tyrosine kinase cooperates with the breakpoint cluster region protein (Bcr) to induce neurite extension in a Rac- and Cdc42-dependent manner.</title>
<authorList>
<person name="Laurent C.E."/>
<person name="Smithgall T.E."/>
</authorList>
<dbReference type="PubMed" id="15302586"/>
<dbReference type="DOI" id="10.1016/j.yexcr.2004.05.010"/>
</citation>
<scope>INTERACTION WITH FES/FPS; ABL1; PIK3R1 AND GRB2</scope>
<scope>MUTAGENESIS OF TYR-177</scope>
<scope>PHOSPHORYLATION AT TYR-246</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2004" name="J. Cell Sci." volume="117" first="5535" last="5541">
<title>Bcr (breakpoint cluster region) protein binds to PDZ-domains of scaffold protein PDZK1 and vesicle coat protein Mint3.</title>
<authorList>
<person name="Malmberg E.K."/>
<person name="Andersson C.X."/>
<person name="Gentzsch M."/>
<person name="Chen J.H."/>
<person name="Mengos A."/>
<person name="Cui L."/>
<person name="Hansson G.C."/>
<person name="Riordan J.R."/>
</authorList>
<dbReference type="PubMed" id="15494376"/>
<dbReference type="DOI" id="10.1242/jcs.01472"/>
</citation>
<scope>INTERACTION WITH PDZK1</scope>
<scope>MUTAGENESIS OF 1269-THR--GLU-1271 AND VAL-1271</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="899" last="911">
<title>Abr and Bcr, two homologous Rac GTPase-activating proteins, control multiple cellular functions of murine macrophages.</title>
<authorList>
<person name="Cho Y.J."/>
<person name="Cunnick J.M."/>
<person name="Yi S.J."/>
<person name="Kaartinen V."/>
<person name="Groffen J."/>
<person name="Heisterkamp N."/>
</authorList>
<dbReference type="PubMed" id="17116687"/>
<dbReference type="DOI" id="10.1128/mcb.00756-06"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF ARG-1090 AND ASN-1202</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="526" last="534">
<title>Phosphoproteome of resting human platelets.</title>
<authorList>
<person name="Zahedi R.P."/>
<person name="Lewandrowski U."/>
<person name="Wiesner J."/>
<person name="Wortelkamp S."/>
<person name="Moebius J."/>
<person name="Schuetz C."/>
<person name="Walter U."/>
<person name="Gambaryan S."/>
<person name="Sickmann A."/>
</authorList>
<dbReference type="PubMed" id="18088087"/>
<dbReference type="DOI" id="10.1021/pr0704130"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-459</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-177; SER-459 AND SER-1264</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122; SER-215 AND SER-459</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.m111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122; SER-139; SER-202; SER-215; SER-222; SER-356; SER-377; SER-459; SER-463; SER-473; SER-488; TYR-554; THR-641; TYR-644; THR-693 AND SER-894</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-459</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2002" name="Nat. Struct. Biol." volume="9" first="117" last="120">
<title>Structure of the Bcr-Abl oncoprotein oligomerization domain.</title>
<authorList>
<person name="Zhao X."/>
<person name="Ghaffari S."/>
<person name="Lodish H."/>
<person name="Malashkevich V.N."/>
<person name="Kim P.S."/>
</authorList>
<dbReference type="PubMed" id="11780146"/>
<dbReference type="DOI" id="10.1038/nsb747"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 3-72</scope>
<scope>HOMOTETRAMERIZATION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2010" name="J. Neurosci." volume="30" first="14134" last="14144">
<title>Regulation of synaptic Rac1 activity, long-term potentiation maintenance, and learning and memory by BCR and ABR Rac GTPase-activating proteins.</title>
<authorList>
<person name="Oh D."/>
<person name="Han S."/>
<person name="Seo J."/>
<person name="Lee J.R."/>
<person name="Choi J."/>
<person name="Groffen J."/>
<person name="Kim K."/>
<person name="Cho Y.S."/>
<person name="Choi H.S."/>
<person name="Shin H."/>
<person name="Woo J."/>
<person name="Won H."/>
<person name="Park S.K."/>
<person name="Kim S.Y."/>
<person name="Jo J."/>
<person name="Whitcomb D.J."/>
<person name="Cho K."/>
<person name="Kim H."/>
<person name="Bae Y.C."/>
<person name="Heisterkamp N."/>
<person name="Choi S.Y."/>
<person name="Kim E."/>
</authorList>
<dbReference type="PubMed" id="20962234"/>
<dbReference type="DOI" id="10.1523/jneurosci.1711-10.2010"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH DLG4</scope>
<scope>MUTAGENESIS OF VAL-1271</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2013" name="J. Cell Biol." volume="202" first="653" last="666">
<title>The GEF Bcr activates RhoA/MAL signaling to promote keratinocyte differentiation via desmoglein-1.</title>
<authorList>
<person name="Dubash A.D."/>
<person name="Koetsier J.L."/>
<person name="Amargo E.V."/>
<person name="Najor N.A."/>
<person name="Harmon R.M."/>
<person name="Green K.J."/>
</authorList>
<dbReference type="PubMed" id="23940119"/>
<dbReference type="DOI" id="10.1083/jcb.201304133"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF 689-ASN-GLU-690</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2014" name="J. Biol. Chem." volume="289" first="35397" last="35408">
<title>src homology 2 domain containing protein 5 (sh2d5) binds the breakpoint cluster region protein, BCR, and regulates levels of Rac1-GTP.</title>
<authorList>
<person name="Gray E.J."/>
<person name="Petsalaki E."/>
<person name="James D.A."/>
<person name="Bagshaw R.D."/>
<person name="Stacey M.M."/>
<person name="Rocks O."/>
<person name="Gingras A.C."/>
<person name="Pawson T."/>
</authorList>
<dbReference type="PubMed" id="25331951"/>
<dbReference type="DOI" id="10.1074/jbc.m114.615112"/>
</citation>
<scope>INTERACTION WITH SH2D5</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] PRO-400; MET-413; GLU-752; SER-796; CYS-910; ILE-949; LYS-1037; MET-1091; ALA-1096; GLY-1104; ASN-1106; THR-1149; LYS-1161; GLU-1187; MET-1189; GLY-1204 AND ARG-1235</scope>
</reference>
<comment type="function">
<text evidence="14 21 22 25 27 33">Protein with a unique structure having two opposing regulatory activities toward small GTP-binding proteins. The C-terminus is a GTPase-activating protein (GAP) domain which stimulates GTP hydrolysis by RAC1, RAC2 and CDC42. Accelerates the intrinsic rate of GTP hydrolysis of RAC1 or CDC42, leading to down-regulation of the active GTP-bound form (PubMed:7479768, PubMed:1903516, PubMed:17116687). The central Dbl homology (DH) domain functions as guanine nucleotide exchange factor (GEF) that modulates the GTPases CDC42, RHOA and RAC1. Promotes the conversion of CDC42, RHOA and RAC1 from the GDP-bound to the GTP-bound form (PubMed:7479768, PubMed:23940119). The amino terminus contains an intrinsic kinase activity (PubMed:1657398). Functions as an important negative regulator of neuronal RAC1 activity (By similarity). Regulates macrophage functions such as CSF1-directed motility and phagocytosis through the modulation of RAC1 activity (PubMed:17116687). Plays a major role as a RHOA GEF in keratinocytes being involved in focal adhesion formation and keratinocyte differentiation (PubMed:23940119).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="21">
<text>ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]</text>
<dbReference type="Rhea" id="RHEA:17989"/>
<dbReference type="Rhea" id="RHEA-COMP:9863"/>
<dbReference type="Rhea" id="RHEA-COMP:11604"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:29999"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:83421"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
<dbReference type="EC" id="2.7.11.1"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="21">
<dbReference type="Rhea" id="RHEA:17990"/>
</physiologicalReaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="21">
<text>ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]</text>
<dbReference type="Rhea" id="RHEA:46608"/>
<dbReference type="Rhea" id="RHEA-COMP:11060"/>
<dbReference type="Rhea" id="RHEA-COMP:11605"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30013"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:61977"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
<dbReference type="EC" id="2.7.11.1"/>
</reaction>
<physiologicalReaction direction="left-to-right" evidence="21">
<dbReference type="Rhea" id="RHEA:46609"/>
</physiologicalReaction>
</comment>
<comment type="subunit">
<text evidence="14 19 20 23 26 29 35">Homotetramer. Interacts with PDZK1 (PubMed:15494376). May interact with CCPG1 (By similarity). Interacts with FES/FPS, ABL1, PIK3R1 and GRB2 (PubMed:15302586, PubMed:1712671, PubMed:9407116). Interacts with HCK (PubMed:9407116). Interacts with SH2D5 (PubMed:25331951). Interacts with DLG4 (PubMed:20962234).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712838">
<id>P11274</id>
</interactant>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712838">
<id>P11274</id>
</interactant>
<interactant intactId="EBI-15101685">
<id>Q6ZV89-1</id>
<label>SH2D5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712838">
<id>P11274</id>
</interactant>
<interactant intactId="EBI-4398527">
<id>Q9H2K2</id>
<label>TNKS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712838">
<id>P11274</id>
</interactant>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712838">
<id>P11274</id>
</interactant>
<interactant intactId="EBI-15101945">
<id>A2AM67</id>
<label>Sh2d5</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-712838">
<id>P11274</id>
</interactant>
<interactant intactId="EBI-15101675">
<id>Q8JZW5</id>
<label>Sh2d5</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-8658094">
<id>P11274-1</id>
</interactant>
<interactant intactId="EBI-968788">
<id>P18031</id>
<label>PTPN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="14">Cell junction</location>
<location evidence="14">Synapse</location>
<location evidence="14">Postsynaptic density</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="14">Cell projection</location>
<location evidence="14">Dendritic spine</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="14">Cell projection</location>
<location evidence="14">Axon</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="13">Cell junction</location>
<location evidence="13">Synapse</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P11274-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P11274-2</id>
<name>2</name>
<sequence type="described" ref="VSP_024352"/>
</isoform>
</comment>
<comment type="domain">
<text>The region involved in binding to ABL1 SH2-domain is rich in serine residues and needs to be Ser/Thr phosphorylated prior to SH2 binding. This region is essential for the activation of the ABL1 tyrosine kinase and transforming potential of the chimeric BCR-ABL oncogene.</text>
</comment>
<comment type="domain">
<text evidence="14">The DH domain is involved in interaction with CCPG1.</text>
</comment>
<comment type="domain">
<text evidence="39">The amino terminus contains an intrinsic kinase activity. The central Dbl homology (DH) domain functions as guanine nucleotide exchange factor (GEF) that modulates the GTPases CDC42, RHOA and RAC1. Promotes the conversion of CDC42, RHOA and RAC1 from the GDP-bound to the GTP-bound form. The C-terminus is a Rho-GAP domain which stimulates GTP hydrolysis by RAC1, RAC2 and CDC42. The protein has a unique structure having two opposing regulatory activities toward small GTP-binding proteins.</text>
</comment>
<comment type="PTM">
<text evidence="19 35">Autophosphorylated. Phosphorylated by FES/FPS on tyrosine residues, leading to down-regulation of the BCR kinase activity. Phosphorylation at Tyr-177 by HCK is important for interaction with GRB2.</text>
</comment>
<comment type="disease" evidence="28 30 32">
<disease id="DI-03735">
<name>Leukemia, chronic myeloid</name>
<acronym>CML</acronym>
<description>A clonal myeloproliferative disorder of a pluripotent stem cell with a specific cytogenetic abnormality, the Philadelphia chromosome (Ph), involving myeloid, erythroid, megakaryocytic, B-lymphoid, and sometimes T-lymphoid cells, but not marrow fibroblasts.</description>
<dbReference type="MIM" id="608232"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease">
<text evidence="30 34">A chromosomal aberration involving BCR has been found in patients with chronic myeloid leukemia. Translocation t(9;22)(q34;q11) with ABL1. The translocation produces a BCR-ABL found also in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).</text>
</comment>
<comment type="sequence caution" evidence="38">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAE06073" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/BCRID55.html"/>
</comment>
<dbReference type="EC" id="2.7.11.1" evidence="21"/>
<dbReference type="EMBL" id="Y00661">
<property type="protein sequence ID" value="CAA68676.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U07000">
<property type="protein sequence ID" value="AAB60388.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB209991">
<property type="protein sequence ID" value="BAE06073.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X02596">
<property type="protein sequence ID" value="CAA26441.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M15025">
<property type="protein sequence ID" value="AAA35594.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X52828">
<property type="protein sequence ID" value="CAA37010.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X52829">
<property type="protein sequence ID" value="CAA37011.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X14676">
<property type="protein sequence ID" value="CAA32806.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M64437">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13806.1">
<molecule id="P11274-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13807.1">
<molecule id="P11274-2"/>
</dbReference>
<dbReference type="PIR" id="A26664">
<property type="entry name" value="TVHUA2"/>
</dbReference>
<dbReference type="PIR" id="A91064">
<property type="entry name" value="TVHUBR"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004318.3">
<molecule id="P11274-1"/>
<property type="nucleotide sequence ID" value="NM_004327.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_067585.2">
<molecule id="P11274-2"/>
<property type="nucleotide sequence ID" value="NM_021574.2"/>
</dbReference>
<dbReference type="PDB" id="1K1F">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B/C/D/E/F/G/H=1-72"/>
</dbReference>
<dbReference type="PDB" id="2AIN">
<property type="method" value="NMR"/>
<property type="chains" value="B=1266-1271"/>
</dbReference>
<dbReference type="PDB" id="5N6R">
<property type="method" value="NMR"/>
<property type="chains" value="A=487-702"/>
</dbReference>
<dbReference type="PDB" id="5N7E">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="B=487-702"/>
</dbReference>
<dbReference type="PDB" id="5OC7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.65"/>
<property type="chains" value="A/D=704-893"/>
</dbReference>
<dbReference type="PDBsum" id="1K1F"/>
<dbReference type="PDBsum" id="2AIN"/>
<dbReference type="PDBsum" id="5N6R"/>
<dbReference type="PDBsum" id="5N7E"/>
<dbReference type="PDBsum" id="5OC7"/>
<dbReference type="SASBDB" id="P11274"/>
<dbReference type="SMR" id="P11274"/>
<dbReference type="BioGRID" id="107083">
<property type="interactions" value="90"/>
</dbReference>
<dbReference type="ELM" id="P11274"/>
<dbReference type="IntAct" id="P11274">
<property type="interactions" value="92"/>
</dbReference>
<dbReference type="MINT" id="P11274"/>
<dbReference type="STRING" id="9606.ENSP00000303507"/>
<dbReference type="BindingDB" id="P11274"/>
<dbReference type="ChEMBL" id="CHEMBL5146"/>
<dbReference type="DrugBank" id="DB06616">
<property type="generic name" value="Bosutinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB01254">
<property type="generic name" value="Dasatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB00619">
<property type="generic name" value="Imatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08901">
<property type="generic name" value="Ponatinib"/>
</dbReference>
<dbReference type="DrugCentral" id="P11274"/>
<dbReference type="iPTMnet" id="P11274"/>
<dbReference type="MetOSite" id="P11274"/>
<dbReference type="PhosphoSitePlus" id="P11274"/>
<dbReference type="BioMuta" id="BCR"/>
<dbReference type="DMDM" id="143811366"/>
<dbReference type="EPD" id="P11274"/>
<dbReference type="jPOST" id="P11274"/>
<dbReference type="MassIVE" id="P11274"/>
<dbReference type="MaxQB" id="P11274"/>
<dbReference type="PaxDb" id="P11274"/>
<dbReference type="PeptideAtlas" id="P11274"/>
<dbReference type="PRIDE" id="P11274"/>
<dbReference type="ProteomicsDB" id="52729">
<molecule id="P11274-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="52730">
<molecule id="P11274-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="9277">
<property type="antibodies" value="633 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000305877">
<molecule id="P11274-1"/>
<property type="protein sequence ID" value="ENSP00000303507"/>
<property type="gene ID" value="ENSG00000186716"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000359540">
<molecule id="P11274-2"/>
<property type="protein sequence ID" value="ENSP00000352535"/>
<property type="gene ID" value="ENSG00000186716"/>
</dbReference>
<dbReference type="GeneID" id="613"/>
<dbReference type="KEGG" id="hsa:613"/>
<dbReference type="UCSC" id="uc002zww.4">
<molecule id="P11274-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="613"/>
<dbReference type="DisGeNET" id="613"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000186716.19"/>
<dbReference type="GeneCards" id="BCR"/>
<dbReference type="HGNC" id="HGNC:1014">
<property type="gene designation" value="BCR"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000186716">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="BCR"/>
<dbReference type="MIM" id="151410">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="608232">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P11274"/>
<dbReference type="OpenTargets" id="ENSG00000186716"/>
<dbReference type="Orphanet" id="521">
<property type="disease" value="Chronic myeloid leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="261330">
<property type="disease" value="Distal 22q11.2 microdeletion syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="99860">
<property type="disease" value="Precursor B-cell acute lymphoblastic leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="99861">
<property type="disease" value="Precursor T-cell acute lymphoblastic leukemia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA25321"/>
<dbReference type="eggNOG" id="KOG4269">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000153491"/>
<dbReference type="HOGENOM" id="CLU_004164_0_0_1"/>
<dbReference type="InParanoid" id="P11274"/>
<dbReference type="KO" id="K08878"/>
<dbReference type="OMA" id="VTMRDHG"/>
<dbReference type="OrthoDB" id="762492at2759"/>
<dbReference type="PhylomeDB" id="P11274"/>
<dbReference type="TreeFam" id="TF105082"/>
<dbReference type="PathwayCommons" id="P11274"/>
<dbReference type="Reactome" id="R-HSA-1839117">
<property type="pathway name" value="Signaling by cytosolic FGFR1 fusion mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-194840">
<property type="pathway name" value="Rho GTPase cycle"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5655302">
<property type="pathway name" value="Signaling by FGFR1 in disease"/>
</dbReference>
<dbReference type="SignaLink" id="P11274"/>
<dbReference type="SIGNOR" id="P11274"/>
<dbReference type="BioGRID-ORCS" id="613">
<property type="hits" value="12 hits in 899 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="BCR">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P11274"/>
<dbReference type="GeneWiki" id="BCR_(gene)"/>
<dbReference type="GenomeRNAi" id="613"/>
<dbReference type="Pharos" id="P11274">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:P11274"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 22"/>
</dbReference>
<dbReference type="RNAct" id="P11274">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000186716">
<property type="expression patterns" value="Expressed in adenohypophysis and 225 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P11274">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P11274">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0030424">
<property type="term" value="C:axon"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043197">
<property type="term" value="C:dendritic spine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098978">
<property type="term" value="C:glutamatergic synapse"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014069">
<property type="term" value="C:postsynaptic density"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0099092">
<property type="term" value="C:postsynaptic density, intracellular component"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0098685">
<property type="term" value="C:Schaffer collateral - CA1 synapse"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0005096">
<property type="term" value="F:GTPase activator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005085">
<property type="term" value="F:guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016301">
<property type="term" value="F:kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0005089">
<property type="term" value="F:Rho guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030036">
<property type="term" value="P:actin cytoskeleton organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0090630">
<property type="term" value="P:activation of GTPase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007420">
<property type="term" value="P:brain development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0071222">
<property type="term" value="P:cellular response to lipopolysaccharide"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060216">
<property type="term" value="P:definitive hemopoiesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048041">
<property type="term" value="P:focal adhesion assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048872">
<property type="term" value="P:homeostasis of number of cells"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042472">
<property type="term" value="P:inner ear morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0065002">
<property type="term" value="P:intracellular protein transmembrane transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030216">
<property type="term" value="P:keratinocyte differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050804">
<property type="term" value="P:modulation of chemical synaptic transmission"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060313">
<property type="term" value="P:negative regulation of blood vessel remodeling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0002692">
<property type="term" value="P:negative regulation of cellular extravasation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050728">
<property type="term" value="P:negative regulation of inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043314">
<property type="term" value="P:negative regulation of neutrophil degranulation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000378">
<property type="term" value="P:negative regulation of reactive oxygen species metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060268">
<property type="term" value="P:negative regulation of respiratory burst"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050885">
<property type="term" value="P:neuromuscular process controlling balance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048008">
<property type="term" value="P:platelet-derived growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050766">
<property type="term" value="P:positive regulation of phagocytosis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0051726">
<property type="term" value="P:regulation of cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051171">
<property type="term" value="P:regulation of nitrogen compound metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035023">
<property type="term" value="P:regulation of Rho protein signal transduction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051056">
<property type="term" value="P:regulation of small GTPase mediated signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043114">
<property type="term" value="P:regulation of vascular permeability"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003014">
<property type="term" value="P:renal system process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007264">
<property type="term" value="P:small GTPase mediated signal transduction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd00160">
<property type="entry name" value="RhoGEF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.555.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.20.900.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.150">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="4.10.280.30">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR037769">
<property type="entry name" value="Abr/Bcr"/>
</dbReference>
<dbReference type="InterPro" id="IPR015123">
<property type="entry name" value="Bcr-Abl_oncoprot_oligo"/>
</dbReference>
<dbReference type="InterPro" id="IPR036481">
<property type="entry name" value="Bcr-Abl_oncoprot_oligo_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000008">
<property type="entry name" value="C2_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR035892">
<property type="entry name" value="C2_domain_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR035899">
<property type="entry name" value="DBL_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000219">
<property type="entry name" value="DH-domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR001331">
<property type="entry name" value="GDS_CDC24_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001849">
<property type="entry name" value="PH_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR008936">
<property type="entry name" value="Rho_GTPase_activation_prot"/>
</dbReference>
<dbReference type="InterPro" id="IPR000198">
<property type="entry name" value="RhoGAP_dom"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR23182">
<property type="entry name" value="PTHR23182"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF09036">
<property type="entry name" value="Bcr-Abl_Oligo"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00168">
<property type="entry name" value="C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00620">
<property type="entry name" value="RhoGAP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00621">
<property type="entry name" value="RhoGEF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00239">
<property type="entry name" value="C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00233">
<property type="entry name" value="PH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00324">
<property type="entry name" value="RhoGAP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00325">
<property type="entry name" value="RhoGEF"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48065">
<property type="entry name" value="SSF48065"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48350">
<property type="entry name" value="SSF48350"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF69036">
<property type="entry name" value="SSF69036"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50004">
<property type="entry name" value="C2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00741">
<property type="entry name" value="DH_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50010">
<property type="entry name" value="DH_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50003">
<property type="entry name" value="PH_DOMAIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50238">
<property type="entry name" value="RHOGAP"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0343">GTPase activation</keyword>
<keyword id="KW-0344">Guanine-nucleotide releasing factor</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0770">Synapse</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="chain" description="Breakpoint cluster region protein" id="PRO_0000080933">
<location>
<begin position="1"/>
<end position="1271"/>
</location>
</feature>
<feature type="domain" description="DH" evidence="16">
<location>
<begin position="498"/>
<end position="691"/>
</location>
</feature>
<feature type="domain" description="PH" evidence="17">
<location>
<begin position="708"/>
<end position="866"/>
</location>
</feature>
<feature type="domain" description="C2" evidence="15">
<location>
<begin position="893"/>
<end position="1020"/>
</location>
</feature>
<feature type="domain" description="Rho-GAP" evidence="18">
<location>
<begin position="1054"/>
<end position="1248"/>
</location>
</feature>
<feature type="region of interest" description="Kinase">
<location>
<begin position="1"/>
<end position="426"/>
</location>
</feature>
<feature type="region of interest" description="Binding to ABL SH2-domain">
<location>
<begin position="197"/>
<end position="385"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Leu">
<location>
<begin position="824"/>
<end position="827"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form BCR-ABL oncogene">
<location>
<begin position="426"/>
<end position="427"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="10">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 11">
<location>
<position position="122"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="139"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by HCK" evidence="8 35">
<location>
<position position="177"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="202"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9 11">
<location>
<position position="215"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="222"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="236"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by FES" evidence="19">
<location>
<position position="246"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="356"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="377"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="382"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="14">
<location>
<position position="385"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 8 9 11 12">
<location>
<position position="459"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="463"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="14">
<location>
<position position="471"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="473"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="488"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="11">
<location>
<position position="554"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="641"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="11">
<location>
<position position="644"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="11">
<location>
<position position="693"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="11">
<location>
<position position="894"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 8">
<location>
<position position="1264"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_024352" evidence="37">
<location>
<begin position="961"/>
<end position="1004"/>
</location>
</feature>
<feature type="sequence variant" description="In a bladder transitional cell carcinoma sample; somatic mutation." id="VAR_041883" evidence="24">
<original>S</original>
<variation>P</variation>
<location>
<position position="400"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56321828." id="VAR_041884" evidence="24">
<original>I</original>
<variation>M</variation>
<location>
<position position="413"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4437065." id="VAR_051983">
<original>K</original>
<variation>T</variation>
<location>
<position position="558"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12484731." id="VAR_041885" evidence="24">
<original>D</original>
<variation>E</variation>
<location>
<position position="752"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs140504." id="VAR_031552" evidence="24 28 30 31 36">
<original>N</original>
<variation>S</variation>
<location>
<position position="796"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35537221." id="VAR_041886" evidence="24">
<original>Y</original>
<variation>C</variation>
<location>
<position position="910"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229038." id="VAR_041887" evidence="24">
<original>V</original>
<variation>I</variation>
<location>
<position position="949"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs776552570." id="VAR_031553" evidence="24">
<original>E</original>
<variation>K</variation>
<location>
<position position="1037"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs778229520." id="VAR_041888" evidence="24">
<original>V</original>
<variation>M</variation>
<location>
<position position="1091"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs745459086." id="VAR_041889" evidence="24">
<original>T</original>
<variation>A</variation>
<location>
<position position="1096"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11558696." id="VAR_041890" evidence="24">
<original>A</original>
<variation>G</variation>
<location>
<position position="1104"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs879255379." id="VAR_041891" evidence="24">
<original>D</original>
<variation>N</variation>
<location>
<position position="1106"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35812689." id="VAR_031554">
<original>T</original>
<variation>M</variation>
<location>
<position position="1127"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs200099830." id="VAR_041892" evidence="24">
<original>A</original>
<variation>T</variation>
<location>
<position position="1149"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_041893" evidence="24">
<original>E</original>
<variation>K</variation>
<location>
<position position="1161"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1195127922." id="VAR_041894" evidence="24">
<original>K</original>
<variation>E</variation>
<location>
<position position="1187"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55816482." id="VAR_041895" evidence="24">
<original>V</original>
<variation>M</variation>
<location>
<position position="1189"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56265970." id="VAR_041896" evidence="24">
<original>A</original>
<variation>G</variation>
<location>
<position position="1204"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55719322." id="VAR_041897" evidence="24">
<original>W</original>
<variation>R</variation>
<location>
<position position="1235"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with FES and GRB2." evidence="19 35">
<original>Y</original>
<variation>F</variation>
<location>
<position position="177"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of RHOA GEF activity." evidence="27">
<original>NE</original>
<variation>AA</variation>
<location>
<begin position="689"/>
<end position="690"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of GAP activity. Loss of GAP activity; when associated with A-1202." evidence="22">
<original>R</original>
<variation>A</variation>
<location>
<position position="1090"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of GAP activity; when associated with A-1090." evidence="22">
<original>N</original>
<variation>A</variation>
<location>
<position position="1202"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes interaction with PDZK1." evidence="20">
<location>
<begin position="1269"/>
<end position="1271"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces interaction with PDZK1. Abolishes interaction with DLG4. No effect on synaptic localization." evidence="20 26">
<original>V</original>
<variation>A</variation>
<location>
<position position="1271"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA68676." ref="1" evidence="38">
<original>M</original>
<variation>I</variation>
<location>
<position position="287"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA68676." ref="1" evidence="38">
<original>G</original>
<variation>D</variation>
<location>
<position position="418"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA68676." ref="1" evidence="38">
<original>E</original>
<variation>K</variation>
<location>
<position position="483"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA68676." ref="1" evidence="38">
<original>F</original>
<variation>S</variation>
<location>
<position position="560"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 11." ref="11" evidence="38">
<original>E</original>
<variation>D</variation>
<location>
<position position="690"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAA26441." ref="4" evidence="38">
<original>D</original>
<variation>E</variation>
<location>
<position position="733"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="4"/>
<end position="14"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="28"/>
<end position="64"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="492"/>
<end position="521"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="524"/>
<end position="531"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="533"/>
<end position="535"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="540"/>
<end position="546"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="547"/>
<end position="549"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="550"/>
<end position="569"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="578"/>
<end position="586"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="588"/>
<end position="611"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="613"/>
<end position="618"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="630"/>
<end position="634"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="639"/>
<end position="651"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="653"/>
<end position="661"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="670"/>
<end position="687"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="694"/>
<end position="697"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="709"/>
<end position="719"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="722"/>
<end position="740"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="751"/>
<end position="758"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="759"/>
<end position="761"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="762"/>
<end position="767"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="830"/>
<end position="838"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="843"/>
<end position="847"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="851"/>
<end position="865"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="876"/>
<end position="885"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="1268"/>
<end position="1271"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1K1F"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2AIN"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5N6R"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5N7E"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5OC7"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="15144186"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="F1LXF1"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q6PAJ1"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00041"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00062"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00145"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00172"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15302586"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15494376"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1657398"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17116687"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1712671"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1903516"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20962234"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23940119"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2407300"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25331951"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3107980"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3285291"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="3540951"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7479768"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7665185"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9407116"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="37" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="3285291"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000305"/>
<evidence key="39" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="7479768"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:1014"/>
</source>
</evidence>
<sequence length="1271" mass="142819" checksum="4BF66FA1E9D205FE" modified="2007-04-03" version="2">MVDPVGFAEAWKAQFPDSEPPRMELRSVGDIEQELERCKASIRRLEQEVNQERFRMIYLQTLLAKEKKSYDRQRWGFRRAAQAPDGASEPRASASRPQPAPADGADPPPAEEPEARPDGEGSPGKARPGTARRPGAAASGERDDRGPPASVAALRSNFERIRKGHGQPGADAEKPFYVNVEFHHERGLVKVNDKEVSDRISSLGSQAMQMERKKSQHGAGSSVGDASRPPYRGRSSESSCGVDGDYEDAELNPRFLKDNLIDANGGSRPPWPPLEYQPYQSIYVGGMMEGEGKGPLLRSQSTSEQEKRLTWPRRSYSPRSFEDCGGGYTPDCSSNENLTSSEEDFSSGQSSRVSPSPTTYRMFRDKSRSPSQNSQQSFDSSSPPTPQCHKRHRHCPVVVSEATIVGVRKTGQIWPNDGEGAFHGDADGSFGTPPGYGCAADRAEEQRRHQDGLPYIDDSPSSSPHLSSKGRGSRDALVSGALESTKASELDLEKGLEMRKWVLSGILASEETYLSHLEALLLPMKPLKAAATTSQPVLTSQQIETIFFKVPELYEIHKEFYDGLFPRVQQWSHQQRVGDLFQKLASQLGVYRAFVDNYGVAMEMAEKCCQANAQFAEISENLRARSNKDAKDPTTKNSLETLLYKPVDRVTRSTLVLHDLLKHTPASHPDHPLLQDALRISQNFLSSINEEITPRRQSMTVKKGEHRQLLKDSFMVELVEGARKLRHVFLFTDLLLCTKLKKQSGGKTQQYDCKWYIPLTDLSFQMVDELEAVPNIPLVPDEELDALKIKISQIKNDIQREKRANKGSKATERLKKKLSEQESLLLLMSPSMAFRVHSRNGKSYTFLISSDYERAEWRENIREQQKKCFRSFSLTSVELQMLTNSCVKLQTVHSIPLTINKEDDESPGLYGFLNVIVHSATGFKQSSNLYCTLEVDSFGYFVNKAKTRVYRDTAEPNWNEEFEIELEGSQTLRILCYEKCYNKTKIPKEDGESTDRLMGKGQVQLDPQALQDRDWQRTVIAMNGIEVKLSVKFNSREFSLKRMPSRKQTGVFGVKIAVVTKRERSKVPYIVRQCVEEIERRGMEEVGIYRVSGVATDIQALKAAFDVNNKDVSVMMSEMDVNAIAGTLKLYFRELPEPLFTDEFYPNFAEGIALSDPVAKESCMLNLLLSLPEANLLTFLFLLDHLKRVAEKEAVNKMSLHNLATVFGPTLLRPSEKESKLPANPSQPITMTDSWSLEVMSQVQVLLYFLQLEAIPAPDSKRQSILFSTEV</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

